Institutional investors purchased a net $499.4 thousand shares of VCEL during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 47.13% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARCHON CAPITAL MANAGEMENT LLC Bought 1.1 Million shares of Vericel Corp
FIRST WASHINGTON CORP. Bought 675.7 Thousand shares of Vericel Corp
THE VANGUARD GROUP, INC. Bought 88.6 Thousand shares of Vericel Corp